International Journal of Clinical Oncology

, Volume 17, Issue 2, pp 174–180 | Cite as

Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion

  • Kazushi Kishi
  • Hiroki Maeda
  • Yasushi Nakamura
  • Shintaro Shirai
  • Morio Sato
Case Report

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is increasing common in various sites; however, MALT lymphoma in the esophagus is still rare, so its diagnostic features have not yet been well recognized and optimal treatment has not been properly discussed. Though radiotherapy is widely preferred for gastric and orbital MALT lymphoma, surgery has been the most frequently reported treatment for esophageal MALT lymphoma. This raises the question: why not radiotherapy for esophageal MALT lymphoma instead of surgery? The only reported case of definitive radiotherapy for esophageal MALT lymphoma lacks follow-up data. Three years ago (2007), we treated a 59-year-old male patient with a large esophageal submucosal tumor, diagnosed as MALT lymphoma, with 36 Gy of solo external beam radiotherapy. The tumor was 15 cm in craniocaudal length, homogeneously weakly contrast-enhanced on X-ray computed tomography (CT), homogeneously hypoechoic and clearly demarcated from the surrounding adventitia, and had a concave pattern between the folds. During and after radiotherapy, no treatment-related complications occurred except for transient Grade 2 leukocytopenia. The tumor showed remarkable reduction and histological negativity in the next month. Over the follow-up period, no recurrence was observed in semiannual PET/CT/MRI studies. Taking the current observation with the well known effectiveness of radiotherapy for MALT lymphoma in various other sites, we recommend considering radiotherapy as a reasonable less-invasive treatment for this rare entity.

Keywords

Radiotherapy Esophagus Mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) Imaging diagnosis MALT1 API2 

Notes

Conflict of interest

No author has any conflict of interest.

References

  1. 1.
    Fernández-Llamazares P, Cruz J, Bianchi A et al (1999) Linfoma no hodgkiniano primario del esófago después de una enfermedad de Hodgkin. Medicina Clínica (Barcelona) 112:356–357Google Scholar
  2. 2.
    Shim CS, Lee JS, Kim JO et al (2003) A case of primary esophageal B-cell lymphoma of MALT type, presenting as a submucosal tumor. J Korean Med Sci 18:120–124PubMedGoogle Scholar
  3. 3.
    Miyazaki T, Kato H, Masuda N et al (2004) Mucosa-associated lymphoid tissue lymphoma of the esophagus: case report and review of the literature. Hepatogastroenterology 51:750–753PubMedGoogle Scholar
  4. 4.
    Ruiz-Carazo E, Lacasa Perez N, Salmeron Ruiz A et al (2008) MALT-type primary lymphoma of the esophagus: imaging findings. Radiologia 50:327–330PubMedCrossRefGoogle Scholar
  5. 5.
    Goto M, Okamoto M, Murakami M et al (2005) Mucosa-associated lymphoid tissue lymphoma of the esophagus, report of a case. Stomach Intest 40:380–384Google Scholar
  6. 6.
    Hosaka S, Nakamura N, Akamatsu T et al (2002) A case of primary low grade mucosa associated lymphoid tissue (MALT) lymphoma of the oesophagus. Gut 51:281–284PubMedCrossRefGoogle Scholar
  7. 7.
    Yano S, Usui N, Dobashi N et al (2009) A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization. Ann Hematol 88:703–704PubMedCrossRefGoogle Scholar
  8. 8.
    Chung JJ, Kim MJ, Kie JH et al (2005) Mucosa-associated lymphoid tissue lymphoma of the esophagus coexistent with bronchus-associated lymphoid tissue lymphoma of the lung. Yonsei Med J 46:562–566PubMedCrossRefGoogle Scholar
  9. 9.
    Guennoun N, Tahri A, Krati K et al (2006) Primary non hodgkin lymphoma of the anus and esophagus: a case report. Gastroenterol Clin Biol 30:487–488PubMedCrossRefGoogle Scholar
  10. 10.
    Soweid AM, Zachary PE Jr (1996) Mucosa-associated lymphoid tissue lymphoma of the oesophagus. Lancet 348:268PubMedCrossRefGoogle Scholar
  11. 11.
    Kitamoto Y, Hasegawa M, Ishikawa H et al (2003) Mucosa-associated lymphoid tissue lymphoma of the esophagus: a case report. J Clin Gastroenterol 36:414–416PubMedCrossRefGoogle Scholar
  12. 12.
    Nishryama Y, Yamamoto Y, Ono Y et al (1999) Visualization of esophageal non-Hodgkin’s lymphoma with Ga-67 scintigraphy. Ann Nucl Med 13:419–421PubMedCrossRefGoogle Scholar
  13. 13.
    Alinari L, Castellucci P, Elstrom R et al (2006) 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 47:2096–2101PubMedCrossRefGoogle Scholar
  14. 14.
    Sugimoto M, Kajimura M, Shirai N et al (2006) Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Intern Med 45:405–409PubMedCrossRefGoogle Scholar
  15. 15.
    Tomita N, Kodaira T, Tachibana H et al (2009) Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma. Radiother Oncol 90:231–235PubMedCrossRefGoogle Scholar
  16. 16.
    Burman C, Kutcher GJ, Emami B et al (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123–135PubMedCrossRefGoogle Scholar
  17. 17.
    Yamashita H, Nakagawa K, Asari T et al (2008) Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 87:412–417PubMedCrossRefGoogle Scholar
  18. 18.
    Ferreri AJ, Dolcetti R, Du MQ et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphoma genesis and microbial-targeted therapy. Ann Oncol 19:835–846PubMedCrossRefGoogle Scholar
  19. 19.
    Park W, Chang SK, Yang WI et al (2004) Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys 58:1480–1486PubMedCrossRefGoogle Scholar
  20. 20.
    Weston AP, Cherian R, Horvat RT et al (1997) Mucosa-associated lymphoid tissue (MALT) in Barrett’s esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori. Am J Gastroenterol 92:800–804PubMedGoogle Scholar
  21. 21.
    Elmore SA (2006) Enhanced histopathology of mucosa-associated lymphoid tissue. Toxicol Pathol 34:687–696PubMedCrossRefGoogle Scholar
  22. 22.
    Raderer M, Paul de Boer J (2010) Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas. Best Pract Res Clin Gastroenterol 24:19–26PubMedCrossRefGoogle Scholar
  23. 23.
    Bentzen SM, Constine LS, Deasy JO et al (2010) Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76:S3–S9PubMedCrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2011

Authors and Affiliations

  • Kazushi Kishi
    • 1
  • Hiroki Maeda
    • 2
  • Yasushi Nakamura
    • 3
  • Shintaro Shirai
    • 4
  • Morio Sato
    • 4
  1. 1.Department of Radiation Oncology, Tumor CenterWakayama Medical University HospitalWakayamaJapan
  2. 2.Department of GastroenterologyWakayama Medical UniversityWakayamaJapan
  3. 3.Department of PathologyWakayama Medical UniversityWakayamaJapan
  4. 4.Department of RadiologyWakayama Medical UniversityWakayamaJapan

Personalised recommendations